• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

RefleXion Medical

RefleXion inks AI partnership for cancer treatment planning

March 28, 2024 By Sean Whooley

RefleXion Medical announced today that it signed a licensing agreement with Limbus AI to incorporate software into radiation treatment planning. The agreement enables the integration of the Limbus Contour automated contour software into the RefleXion X1 system. X1 uses biology-guided radiotherapy (BgRT) technology. It enables a PET radiotracer to create a unified motion management solution […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Health Technology, Imaging, Machine Learning (ML), Oncology, Radiosurgery/Radiation therapy, Software / IT Tagged With: Limbus AI, RefleXion Medical

First cancer patient treated with RefleXion biology-guided radiotherapy

August 23, 2023 By Sean Whooley

RefleXion Medical announced today that the first patient completed treatment with Scintix biology-guided radiotherapy on its X1 machine. Scintix treats early- and late-stage cancers using the individual biology of each tumor to drive its own treatment. It allows each cancer’s unique biology to autonomously determine how much radiation to deliver. This occurs on a second-by-second […]

Filed Under: Business/Financial News, Featured, Imaging, News Well, Oncology, Radiosurgery/Radiation therapy Tagged With: RefleXion Medical

FDA clears biology-guided radiotherapy from RefleXion

February 2, 2023 By Sean Whooley

RefleXion Medical announced today that the FDA cleared its Scintix biology-guided radiotherapy treatment for cancer. Hayward, California-based RefleXion designed the Scintix platform for use in treating both early- and late-stage cancers. The company said Scintix is the first and only radiotherapy that allows each cancer’s unique biology to autonomously determine how much radiation to deliver. […]

Filed Under: 510(k), Business/Financial News, Featured, Food & Drug Administration (FDA), Imaging, News Well, Oncology, Radiosurgery/Radiation therapy, Regulatory/Compliance Tagged With: FDA, RefleXion Medical

RefleXion expands footprint through multi-system contract with Select Healthcare

August 18, 2022 By Sean Whooley

RefleXion Medical announced today that it entered into a three-system contract with Select Healthcare cancer facility developer. The multi-year, multi-site contract was agreed upon with the aim of creating new, free-standing treatment centers using the RefleXion X1 platform for treating all stages of cancer with external beam radiotherapy (EBRT). RefleXion said in a news release […]

Filed Under: Business/Financial News, Imaging, Oncology, Radiosurgery/Radiation therapy Tagged With: RefleXion Medical, Select Healthcare

RefleXion, Mirada ink licensing deal on personalized cancer treatment

July 7, 2022 By Sean Whooley

RefleXion Medical announced today that it entered into a non-exclusive, worldwide licensing agreement with Mirada Medical. The agreement allows for the integration of Mirada’s RegEngine image registration algorithms into the RefleXion X1 treatment planning software, aligning patient anatomy between different imaging modalities or between radiotherapy treatments. “Day-of-treatment modifications, called adaptive radiotherapy, are critical for responding […]

Filed Under: Business/Financial News, Health Technology, Imaging, Oncology, Radiosurgery/Radiation therapy, Software / IT Tagged With: Mirada Medical, RefleXion Medical

RefleXion closes $125M debt facility

July 6, 2022 By Sean Whooley

Biology-guided radiotherapy (BgRT) technology developer RefleXion Medical announced today that it closed a $125 million debt facility. Hayward, California–based RefleXion has $55 million of the $125 million total available immediately to repay its existing $50 million in debt. The remaining $70 million will be made available upon the achievement of certain regulatory and commercial milestones. […]

Filed Under: Business/Financial News, Funding Roundup, Oncology, Radiosurgery/Radiation therapy Tagged With: Oxford Finance, RefleXion Medical

RefleXion raises $80M for biology-guided radiotherapy tech

March 11, 2022 By Sean Whooley

RefleXion Medical announced that it closed an $80 million equity financing to support its therapeutic oncology technology. Hayward, California-based RefleXion develops biology-guided radiotherapy (BgRT) for all stages of cancer. The company designed BgRT to transform an injected radiotracer into a unified motion management solution that overcomes the technical limitations currently restricting radiotherapy use to one […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Oncology, Radiosurgery/Radiation therapy Tagged With: RefleXion Medical

RefleXion, Merck team up on late-stage cancer study

May 28, 2020 By Sean Whooley

RefleXion announced today that it entered into a clinical collaboration with Merck to evaluate Merck’s (NYSE:MRK) Keytruda anti-PD-1 therapy in clinical trials. Hayward, Calif.-based therapeutic oncology company RefleXion is joining forces with Merck to evaluate Keytruda’s safety and efficacy in combination with RefleXion’s biology-guided radiotherapy (BgRT) in multiple late-stage cancers, including non-small cell lung cancer, in […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Imaging, Oncology, Radiosurgery/Radiation therapy Tagged With: Merck, RefleXion Medical

RefleXion Medical raises $100m for biology-guided cancer radiotherapy

April 16, 2020 By Sean Whooley

Therapeutic oncology company RefleXion Medical announced today that it closed an equity financing with proceeds of $100 million. Public Sector Pension Investment Board (PSP Investments), a large, Canada-based pension investment manager focused on long-term investments, led the funding, according to a news release. Existing investors TPG’s The Rise Fund, KCK Group, Sofinnova Partners, Venrock, T. […]

Filed Under: Business/Financial News, Food & Drug Administration (FDA), Funding Roundup, Oncology, Radiosurgery/Radiation therapy, Regulatory/Compliance Tagged With: FDA, RefleXion Medical

Medtech companies raised more than $738 million in Q2

July 20, 2018 By Danielle Kirsh

Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1. […]

Filed Under: Business/Financial News Tagged With: Acutus Medical, Avedro, Axonics Modulation Technologies, Cardiac Dimensions, Cardiofocus, Cytrellis Biosystems, Eargo, Mevion Medical Systems, RefleXion Medical, Relievant Medsystems, venture capital

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy